According to Tandem Diabetes Care 's latest financial reports the company's current EPS (TTM) is -$3.23. In 2022 the company made an earnings per share (EPS) of -$1.47 a decrease over its 2021 EPS that were of $0.24.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.23 | 119.73% |
2022 | -$1.47 | -712.5% |
2021 | $0.24 | -141.38% |
2020 | -$0.58 | 31.82% |
2019 | -$0.44 | -87.61% |
2018 | -$3.55 | -78% |
2017 | -$16.14 | -40.94% |
2016 | -$27.33 | 8.02% |
2015 | -$25.30 | -26.02% |
2014 | -$34.20 | -8.82% |
2013 | -$37.51 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | -536.08% | ๐บ๐ธ USA |
Medtronic MDT | $2.72 | -184.21% | ๐ฎ๐ช Ireland |
ICU Medical
ICUI | -$2.02 | -37.46% | ๐บ๐ธ USA |
DexCom DXCM | $0.98 | -130.34% | ๐บ๐ธ USA |
Insulet PODD | $1.72 | -153.25% | ๐บ๐ธ USA |